Clindamycin vs Upadacitinib

Clindamycin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Clindamycin and Upadacitinib.

Mechanism of Action

Clindamycin: Binds 50S ribosomal subunit inhibiting protein synthesis.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Clindamycin — 2-3 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Clindamycin — C18H33ClN2O5S; Upadacitinib — C17H19F3N6O.

Molecular Weight: Clindamycin — 424.9830 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Clindamycin — Small molecule; Upadacitinib — Small molecule.